Nerai

Genorare

This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.

Nephrogen

This biotechnology company develops artificial intelligence-driven gene therapies to treat kidney and pancreatic diseases for patients with genetic conditions.

Xaira

The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.

Algen Biotechnologies

This company develops a CRISPR and artificial intelligence platform to discover drugs for pharmaceutical partners and its own therapeutic pipeline.

Dogma Biotech

This company develops AI-designed glycans to enhance protein therapeutic performance for patients with central nervous system and lysosomal storage diseases.

Kerna

This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.

Airna

This company develops RNA editing therapeutics to treat patients with rare genetic and common cardiometabolic diseases.

Profluent

This company develops generative artificial intelligence models to design novel proteins and gene editors for pharmaceutical, biotechnology and agricultural organisations.